Royal Bank of Canada Portfolio holdings
Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$2.42B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$1.66B |
| 3 |
CRH
CRH
|
+$671M |
| 4 |
Apple
AAPL
|
+$505M |
| 5 |
Microsoft
MSFT
|
+$501M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$3.55B |
| 2 |
Toronto Dominion Bank
TD
|
+$581M |
| 3 |
Bank of Montreal
BMO
|
+$498M |
| 4 |
Canadian Natural Resources
CNQ
|
+$492M |
| 5 |
Starbucks
SBUX
|
+$487M |
Sector Composition
| 1 | Technology | 19.06% |
| 2 | Financials | 18.37% |
| 3 | Industrials | 7.87% |
| 4 | Healthcare | 7.61% |
| 5 | Consumer Discretionary | 6.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
5051
Intellinetics
INLX
$55.7M
| $63K | ﹤0.01% |
9,900
-8,900
| -47% | -$56.6K |
|
5052
TCW Transform 500 ETF
VOTE
$897M
| $63K | ﹤0.01% |
989
-3,176
| -76% | -$202K |
|
5053
Digimarc
DMRC
$216M
| $62K | ﹤0.01% |
1,990
+615
| +45% | +$19.2K |
|
5054
Evolus
EOLS
$429M
| $62K | ﹤0.01% |
5,783
+2,847
| +97% | +$30.5K |
|
5055
Gannett
GCI
$641M
| $62K | ﹤0.01% |
13,394
+6,906
| +106% | +$32K |
|
5056
Heidrick & Struggles
HSII
$1.04B
| $62K | ﹤0.01% |
1,946
+1,366
| +236% | +$43.5K |
|
5057
MeridianLink
MLNK
$1.47B
| $62K | ﹤0.01% |
2,919
+2,265
| +346% | +$48.1K |
|
5058
Orthofix Medical
OFIX
$583M
| $62K | ﹤0.01% |
4,635
+2,133
| +85% | +$28.5K |
|
|
ONCY
5059
Oncolytics Biotech
ONCY
$126M
| $62K | ﹤0.01% |
62,267
+1,234
| +2% | +$1.23K |
|
5060
Rigetti Computing
RGTI
$6.23B
| $62K | ﹤0.01% |
58,526
+57,197
| +4,304% | +$60.6K |
|
|
SBR
5061
Sabine Royalty Trust
SBR
$1.12B
| $62K | ﹤0.01% |
963
-225
| -19% | -$14.5K |
|
5062
Travere Therapeutics
TVTX
$2.05B
| $62K | ﹤0.01% |
7,544
+3,986
| +112% | +$32.8K |
|
5063
FT Vest US Equity Enhance & Moderate Buffer ETF July
XJUL
$47.8M
| $62K | ﹤0.01% |
+1,836
| New | +$62K |
|
|
QVCGA
5064
QVC Group, Inc. Series A Common Stock
QVCGA
$97.7M
| $62K | ﹤0.01% |
1,966
-1,810
| -48% | -$57.1K |
|
5065
Actinium Pharmaceuticals
ATNM
$50.5M
| $61K | ﹤0.01% |
8,194
+2,706
| +49% | +$20.1K |
|
5066
Greif Class B
GEF.B
$2.46B
| $61K | ﹤0.01% |
991
+301
| +44% | +$18.5K |
|
5067
Goldman Sachs Hedge Industry VIP ETF
GVIP
$394M
| $61K | ﹤0.01% |
551
| – | – |
|
5068
Heron Therapeutics
HRTX
$190M
| $61K | ﹤0.01% |
17,208
+5,172
| +43% | +$18.3K |
|
5069
FT Vest Growth-100 Buffer ETF December
QDEC
$534M
| $61K | ﹤0.01% |
+2,356
| New | +$61K |
|
5070
Relay Therapeutics
RLAY
$700M
| $61K | ﹤0.01% |
9,386
+7,264
| +342% | +$47.2K |
|
5071
Xeris Biopharma Holdings
XERS
$1.19B
| $61K | ﹤0.01% |
27,347
+8,813
| +48% | +$19.7K |
|
5072
Yext
YEXT
$1.08B
| $61K | ﹤0.01% |
11,186
+1,747
| +19% | +$9.53K |
|
5073
CorMedix
CRMD
$944M
| $60K | ﹤0.01% |
13,889
+7,079
| +104% | +$30.6K |
|
5074
Dianthus Therapeutics
DNTH
$1.47B
| $60K | ﹤0.01% |
2,329
+2,248
| +2,775% | +$57.9K |
|
5075
Femasys
FEMY
$11.9M
| $60K | ﹤0.01% |
52,935
| – | – |
|